|
JPS5522636A
(en)
*
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
|
JPS5697277A
(en)
*
|
1980-01-07 |
1981-08-05 |
Takeda Chem Ind Ltd |
Thiazolidine derivative
|
|
US5039665A
(en)
*
|
1980-07-21 |
1991-08-13 |
Markov Angel K |
Use of fructose-1,6-diphosphate for treating myocardial infarction
|
|
US4546095A
(en)
*
|
1980-07-21 |
1985-10-08 |
Markov Angel K |
Use of fructose-1,6-diphosphate for treating myocardial infarction
|
|
US4873191A
(en)
*
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
JPS58118577A
(ja)
*
|
1982-01-07 |
1983-07-14 |
Takeda Chem Ind Ltd |
チアゾリジン誘導体
|
|
US4540564A
(en)
*
|
1982-05-18 |
1985-09-10 |
University Of Florida |
Brain-specific drug delivery
|
|
US4757052A
(en)
*
|
1982-09-03 |
1988-07-12 |
Markov Angel K |
Method of preserving blood
|
|
US4775665A
(en)
*
|
1983-05-16 |
1988-10-04 |
Massachusetts Institute Of Technology |
Method and composition for treating neurological disorders and aging
|
|
JPS6051189A
(ja)
*
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
|
CN1003445B
(zh)
*
|
1984-10-03 |
1989-03-01 |
武田药品工业株式会社 |
噻唑烷二酮衍生物，其制备方法和用途
|
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US4965188A
(en)
*
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
US4683195A
(en)
*
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4703040A
(en)
*
|
1985-04-03 |
1987-10-27 |
Markov Angel K |
Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
|
|
WO1986007056A1
(en)
*
|
1985-05-21 |
1986-12-04 |
Pfizer Inc. |
Hypoglycemic thiazolidinediones
|
|
US5039794A
(en)
*
|
1986-09-19 |
1991-08-13 |
Otsuka Pharmaceutical Co., Ltd. |
Tumor egress factor and processes for producing the same
|
|
US4873255A
(en)
*
|
1987-02-04 |
1989-10-10 |
Sankyo Company Limited |
Thiazolidinone derivatives, their preparation and their use
|
|
FI91869C
(fi)
*
|
1987-03-18 |
1994-08-25 |
Tanabe Seiyaku Co |
Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
|
|
NL8800823A
(nl)
*
|
1987-04-10 |
1988-11-01 |
Sandoz Ag |
Werkwijze voor het toepassen van dopamine-receptor agonisten en farmaceutische preparaten die deze agonisten bevatten.
|
|
EP0295828A1
(en)
*
|
1987-06-13 |
1988-12-21 |
Beecham Group Plc |
Novel compounds
|
|
US5260445A
(en)
*
|
1987-09-04 |
1993-11-09 |
Beecham Group P.L.C. |
2,4-thiazolidinediones
|
|
US5194443A
(en)
*
|
1987-09-04 |
1993-03-16 |
Beecham Group P.L.C. |
Compounds
|
|
US5232925A
(en)
*
|
1987-09-04 |
1993-08-03 |
Beecham Group P.L.C. |
Compounds
|
|
SG59988A1
(en)
*
|
1987-09-04 |
1999-02-22 |
Beecham Group Plc |
Substituted thiazolidinedione derivatives
|
|
US4980350A
(en)
*
|
1988-02-25 |
1990-12-25 |
Merck & Co., Inc. |
Piperazinylalkylpyrimidines as hypoglycemic agents
|
|
WO1989008650A1
(en)
*
|
1988-03-08 |
1989-09-21 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
US5120754A
(en)
*
|
1988-03-08 |
1992-06-09 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
US5223522A
(en)
*
|
1988-03-08 |
1993-06-29 |
Pfizer Inc. |
Thiazolidinedione hypoglycemic agents
|
|
MX15171A
(es)
|
1988-03-08 |
1993-05-01 |
Pfizer |
Derivados de tiazolidinodiona hipoglicemicos
|
|
US5468755A
(en)
*
|
1988-05-10 |
1995-11-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Therapeutic process for the treatment of the pathologies of Type II diabetes
|
|
US5208250A
(en)
*
|
1988-05-25 |
1993-05-04 |
Warner-Lambert Company |
Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
|
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
|
GB8901778D0
(en)
|
1989-01-27 |
1989-03-15 |
Univ Court Of The University O |
Manipulatory technique
|
|
US4897405A
(en)
*
|
1989-04-21 |
1990-01-30 |
American Home Products Corporation |
Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
|
|
GB8919434D0
(en)
*
|
1989-08-25 |
1989-10-11 |
Beecham Group Plc |
Novel compounds
|
|
WO1991007107A1
(en)
|
1989-11-13 |
1991-05-30 |
Pfizer Inc. |
Oxazolidinedione hypoglycemic agents
|
|
US5143928A
(en)
*
|
1990-03-27 |
1992-09-01 |
Warner-Lambert Company |
3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
|
|
EP0526598B1
(en)
*
|
1990-04-27 |
1996-12-18 |
Orion-Yhtymà Oy |
New pharmacologically active catechol derivatives
|
|
GB9017218D0
(en)
|
1990-08-06 |
1990-09-19 |
Beecham Group Plc |
Novel compounds
|
|
FI930772A0
(fi)
*
|
1990-08-23 |
1993-02-22 |
Pfizer |
Hydroxiureaderivat som saenker glugosnivao i blodet
|
|
US5364769A
(en)
*
|
1990-09-25 |
1994-11-15 |
Genentech, Inc. |
Nucleic acid encoding neurotrophic factor four (NT-4), vectors, host cells and methods of production
|
|
US6746678B1
(en)
*
|
1991-02-22 |
2004-06-08 |
Howard K. Shapiro |
Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
|
|
US5668117A
(en)
*
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US5192753A
(en)
|
1991-04-23 |
1993-03-09 |
Mcgeer Patrick L |
Anti-rheumatoid arthritic drugs in the treatment of dementia
|
|
US5143929A
(en)
*
|
1991-05-09 |
1992-09-01 |
Warner-Lambert Company |
2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
|
|
US5164384A
(en)
*
|
1991-06-19 |
1992-11-17 |
Metagenics, Inc. |
Anabolic mineral formula
|
|
US5714470A
(en)
*
|
1991-08-22 |
1998-02-03 |
Merrell Pharmaceuticals, Inc. |
Orally-active elastase inhibitors
|
|
US5270319A
(en)
*
|
1991-09-09 |
1993-12-14 |
Warner-Lambert Company |
5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
|
|
US5256697A
(en)
*
|
1992-04-16 |
1993-10-26 |
Abbott Laboratories |
Method of administering pyruvate and methods of synthesizing pyruvate precursors
|
|
US5326770A
(en)
*
|
1992-07-17 |
1994-07-05 |
The Du Pont Merck Pharmaceutical Company |
Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals
|
|
IT1260155B
(it)
*
|
1992-08-03 |
1996-03-28 |
Fidia Spa |
Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
|
|
GB2269992A
(en)
|
1992-08-14 |
1994-03-02 |
Rh Ne Poulenc Rorer Limited |
Powder inhalation formulations
|
|
EP0915090A1
(en)
*
|
1992-09-10 |
1999-05-12 |
Eli Lilly And Company |
Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
|
|
US5543297A
(en)
*
|
1992-12-22 |
1996-08-06 |
Merck Frosst Canada, Inc. |
Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
|
|
WO1994016722A1
(en)
*
|
1993-01-25 |
1994-08-04 |
The Beth Israel Hospital Association |
Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties
|
|
FI954738A7
(fi)
*
|
1993-04-06 |
1995-12-05 |
Abbott Lab |
Tetrasykliini yhdisteet dopamiiniagonisteina
|
|
KR100392244B1
(ko)
|
1993-04-20 |
2003-11-28 |
더 제너럴 호스피탈 코포레이션 |
신경사단백질유전자발현및알쯔하이머병의검출
|
|
US5360614A
(en)
*
|
1993-04-26 |
1994-11-01 |
The Estee Corporation |
Method of controlling the release of carbohydrates by encapsulation and composition therefor
|
|
US5457109A
(en)
*
|
1993-09-15 |
1995-10-10 |
Warner-Lambert Company |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
|
|
US5395822A
(en)
*
|
1993-09-20 |
1995-03-07 |
Izumi; Yukitoshi |
Use of pyruvate to prevent neuronal degeneration associated with ischemia
|
|
AU693489B2
(en)
*
|
1993-11-15 |
1998-07-02 |
Celtrix Pharmaceuticals, Inc. |
Method of treating neurological disorders
|
|
JPH09511492A
(ja)
*
|
1994-02-03 |
1997-11-18 |
ザ ピコワー インスティテュート フォア メディカル リサーチ |
アミロイドーシスの前進性グリコシル化終末産物仲介モジュレーション用組成物及び方法
|
|
JPH07238035A
(ja)
*
|
1994-02-28 |
1995-09-12 |
Kyowa Hakko Kogyo Co Ltd |
βアミロイド蛋白質分解剤
|
|
US6251928B1
(en)
*
|
1994-03-16 |
2001-06-26 |
Eli Lilly And Company |
Treatment of alzheimer's disease employing inhibitors of cathepsin D
|
|
US5534615A
(en)
*
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US5594015A
(en)
*
|
1994-06-22 |
1997-01-14 |
Regents Of The University Of California |
Thiazolidine derivatives for the treatment of psoriasis
|
|
AU3146495A
(en)
|
1994-07-22 |
1996-02-22 |
Eastern Washington University |
Methods for stereotactic implantation
|
|
US5483070A
(en)
*
|
1994-08-02 |
1996-01-09 |
Packard Instrument Company |
Scintillation counter
|
|
US5607967A
(en)
*
|
1994-10-27 |
1997-03-04 |
Merck & Co., Inc. |
Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
|
|
US5641796A
(en)
*
|
1994-11-01 |
1997-06-24 |
Eli Lilly And Company |
Oral hypoglycemic agents
|
|
US5602121A
(en)
*
|
1994-12-12 |
1997-02-11 |
Allelix Biopharmaceuticals, Inc. |
Alkyl-substituted compounds having dopamine receptor affinity
|
|
US5602120A
(en)
*
|
1994-12-12 |
1997-02-11 |
Allelix Biopharmaceuticals, Inc. |
Benzyl-substituted compounds having dopamine receptor affinity
|
|
US5824692A
(en)
*
|
1995-01-06 |
1998-10-20 |
Lippiello; Patrick Michael |
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
|
|
US6022897A
(en)
|
1995-04-25 |
2000-02-08 |
The Salk Institute For Biological Studies |
Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
|
|
US5708012A
(en)
*
|
1995-04-28 |
1998-01-13 |
Sankyo Company, Limited |
Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
|
|
US5707971A
(en)
*
|
1995-06-07 |
1998-01-13 |
Life Resuscitation Technologies, Inc. |
Modulation of glycolytic ATP production
|
|
US5618835A
(en)
*
|
1996-02-01 |
1997-04-08 |
The Procter & Gamble Company |
Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
|
|
IN182496B
(https=)
*
|
1996-02-20 |
1999-04-17 |
Reddy Research Foundation |
|
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
|
US5783556A
(en)
*
|
1996-08-13 |
1998-07-21 |
Genentech, Inc. |
Formulated insulin-containing composition
|
|
GB9627005D0
(en)
|
1996-12-27 |
1997-02-12 |
Knoll Ag |
Therapeutic agents
|
|
GB9627006D0
(en)
|
1996-12-27 |
1997-02-12 |
Knoll Ag |
Therapeutic agents
|
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
|
US5814647A
(en)
*
|
1997-03-04 |
1998-09-29 |
Board Of Regents, The University Of Texas System |
Use of troglitazone and related compounds for the treatment of the climacteric symptoms
|
|
EP1006794B1
(en)
*
|
1997-03-12 |
2007-11-28 |
Robert W. Esmond |
A method for treating or preventing alzheimer's disease
|
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
|
US5925657A
(en)
*
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
|
US5789401A
(en)
*
|
1997-08-08 |
1998-08-04 |
Nutrition 21 |
High-dose chromium/biotin treatment of type II diabetes
|
|
CA2311125C
(en)
*
|
1997-11-19 |
2011-01-18 |
Takeda Chemical Industries, Ltd. |
Apoptosis inhibitor
|
|
US20040058873A1
(en)
*
|
1998-03-12 |
2004-03-25 |
Esmond Robert W. |
Method for treating or preventing Alzheimer's disease
|
|
US6028088A
(en)
*
|
1998-10-30 |
2000-02-22 |
The University Of Mississippi |
Flavonoid derivatives
|
|
US6191154B1
(en)
*
|
1998-11-27 |
2001-02-20 |
Case Western Reserve University |
Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
|